Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS · Delayed Price · Currency is USD
0.0927
+0.0027 (3.00%)
Jul 27, 2026, 3:25 PM EST
KBLB Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3.97 | -3.62 | -3.4 | -3.03 | -3.84 | -8.05 |
Depreciation & Amortization | 0.09 | 0.09 | 0.09 | 0.05 | 0.08 | 0.03 |
Other Amortization | - | - | - | - | 1.11 | 4.7 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.05 |
Asset Writedown & Restructuring Costs | - | - | - | 0.1 | - | - |
Loss (Gain) From Sale of Investments | -0.2 | -0.2 | - | - | - | - |
Stock-Based Compensation | 1.3 | 1.12 | 0.86 | 0.76 | 0.23 | 0.84 |
Other Operating Activities | 0 | -0.09 | -0.12 | 0 | 0.03 | 0.01 |
Change in Inventory | -0.07 | -0.02 | - | -0 | -0.01 | - |
Change in Accounts Payable | -0.01 | -0.01 | -0.04 | 0 | 0.14 | 0.2 |
Change in Other Net Operating Assets | 0.97 | 0.96 | 0.77 | 0.87 | 0.37 | 0.42 |
Operating Cash Flow | -1.88 | -1.79 | -1.84 | -1.24 | -1.89 | -1.8 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.02 | -0.01 | -0 | -0.01 | -0.01 | -0.1 |
Investment in Securities | 0.44 | 0.44 | - | - | - | -0.45 |
Investing Cash Flow | 0.42 | 0.44 | -0 | -0.01 | -0.01 | -0.55 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | 2.76 | 3.67 |
Total Debt Issued | - | - | - | - | 2.76 | 3.67 |
Short-Term Debt Repaid | - | -0.13 | -0.04 | - | -0.04 | - |
Long-Term Debt Repaid | - | - | - | -0.06 | -0.06 | -0.05 |
Total Debt Repaid | -0.13 | -0.13 | -0.04 | -0.06 | -0.1 | -0.05 |
Net Debt Issued (Repaid) | -0.13 | -0.13 | -0.04 | -0.06 | 2.66 | 3.62 |
Issuance of Common Stock | 2.6 | 2.6 | - | - | 0.74 | 0.27 |
Other Financing Activities | 1.48 | -0.01 | - | - | - | - |
Financing Cash Flow | 3.95 | 2.47 | -0.04 | -0.06 | 3.4 | 3.89 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 2.49 | 1.12 | -1.88 | -1.31 | 1.51 | 1.54 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.9 | -1.79 | -1.84 | -1.25 | -1.89 | -1.9 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Levered Free Cash Flow | -0.36 | -0.33 | -0.6 | -0.26 | -0.57 | 0.82 |
Unlevered Free Cash Flow | -0 | 0.03 | -0.26 | 0.04 | -0.6 | -0.53 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | 0.9 | 0.92 | 0.73 | 0.87 | 0.5 | 0.62 |